Piper Sandler lowers Oklo stock price target on higher capex estimates

Piper Sandler cut its Oklo price target to $49 from $55 while maintaining an Overweight rating, citing higher estimated plant capex of $7,000/kW versus $4,000/kW and a modeling shift toward named plants. Oklo shares are down 61% year to date and trade near their 52-week low; the company is unprofitable but has more cash than debt. Separately, Oklo announced an at-the-market offering program that could raise up to $1 billion, while Piper expects fuller project and cost guidance at a Spring 2027 capital markets day.

Analysis

The key change is to project economics, not the target-price cut itself: a materially higher assumed cost per unit of capacity raises the funding burden and makes each future power-purchase agreement, fuel-cost disclosure, and construction milestone more consequential. The announced ATM creates a second-order overhang: even with cash exceeding debt, the market must discount potential dilution before it knows the pace or price of issuance. Financing capacity is therefore not the same as proof of attractive project returns.

Near term, expect volatility around any actual ATM sales or project-award disclosure; absent those, analyst target dispersion is a weak catalyst. Over 1–3 months, monitor cash burn, financing activity, and whether management gives verifiable cost and customer-conversion detail. Over 6–18 months, regulatory timing and plant execution matter more than pipeline announcements. The DOE safety milestone described for the Idaho work should not be treated as resolving the separate NRC review path referenced for the Meta project.

Contrarian point: the large year-to-date drawdown may price in substantial execution risk, so a lower target alone is not a short thesis. But the bullish case needs funded, named projects with credible economics—not just a long-dated opportunity set. Upside risks include new awards, better-than-expected project costs, or meaningful isotope revenue. The thesis weakens if ATM issuance is limited and disclosed contracts support returns; it strengthens if dilution accelerates, costs rise again, or regulatory timing slips.

Key Decisions for Investors

• Keep OKLO underweight/watch rather than initiating a fresh outright short solely on this note; the company-specific catalyst optionality makes a low-price short vulnerable to sharp squeezes.
• Do not add on valuation or analyst-target arguments alone. Reassess after the next disclosure of ATM utilization, cash burn, named-plant capex, and contract economics; require evidence that funding needs and project returns are reconcilable.
• For an existing long, size against dilution and schedule risk: trim or hedge if ATM sales become material relative to trading liquidity, or if management pushes the NRC timetable beyond the stated planning window.
• Falsifiers to the cautious view: limited equity issuance alongside firm project-cost guidance and signed, economically detailed customer agreements. Negative confirmation: rising capital-cost estimates, worsening cash burn, or a regulatory delay without a credible revised schedule.